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with OAB was collected. Baseline mean health state values
ranged from 0.92 to 0.994. Post 12 weeks treatment mean health
state values ranged from 0.936 to 0.991. The observed im-
provements in health state values are consistent with results
obtained during validation of the model. CONCLUSIONS:
Although modest, these improvements may be expected to be sig-
niﬁcant and are consistent with observed reductions in KHQ
scores.
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OBJECTIVE: King’s Health Questionnaire (KHQ) is a self-
administered, 32-item, 8-domain, urinary incontinence-speciﬁc
quality of life (QOL) instrument. A critical appraisal of the 
literature was conducted to assess its psychometric properties
across all available language versions. METHODS: Computer
searches limited to English language and Humans were con-
ducted using PubMed with keywords “KHQ” or “king’s health
questionnaire”. When articles ascertained through these searches
referenced additional citations, we retrieved them. Exclusion cri-
teria were: review articles, no information on psychometric prop-
erties, related to short-form KHQ, or KHQ was used to validate
other QOL measures. RESULTS: We found 11 articles that met
the inclusion criteria. Item generation included data from over
1,100 patients, inputs from clinicians, and items from existing
instruments. Eight articles were on English version-KHQ, and 3
were on Portuguese-, German-, and Japanese-KHQ (one article
per language). Cronbach’s was °Y´0.7 for English- and German-
KHQ. The range was wider for Portuguese-, and Japanese-KHQ
(0.47–0.88 and 0.63–0.90, respectively). English-KHQ had a
high test-retest reliability across all 8 domains (Spearman’s ||Ñ =
0.80–0.96). KHQ had face and content validity. KHQ was used
in multiple clinical trials and it underwent a systematic transla-
tion process involving forward translation, backward transla-
tion, and cultural adaptation. Correlation coefﬁcients between
KHQ and SF-36 domains were (-0.32 to -0.73) and (-0.26 to
-0.63) for English- and German-KHQ. Internal responsiveness
was shown in Portuguese-KHQ with the mean standardized
response mean ranging -0.54 to -1.61. Using both distribution-
and anchor-based methods, a change from baseline of at least 5
points on KHQ domains meant a minimal important difference.
CONCLUSION: The KHQ is reliable and has good face and
content validity, responsiveness, and interpretability. Construct
validity was variable across different language versions and
KHQ domains. Thus, we recommend additional research on
construct validity, especially in European populations.
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OBJECTIVE: Quality-adjusted life years (QALYs), which rely on
preference-based measures of health, are widely used as outcome
measures in cost-effectiveness studies. However, for Overactive
Bladder (OAB), none of the existing disease-speciﬁc measures are
preference-based, whereas existing generic preference-based
measures of health have been shown to be insensitive in OAB
patients. The purpose of this study is to estimate a preference-
based single index using the validated Overactive Bladder Ques-
tionnaire (OAB-q). METHODS: Psychometric criteria were used
to select a subset of the 33 OAB-q items to form a new classiﬁ-
cation amenable to valuation. This reduced system has 5 dimen-
sions; each with 5 rating levels ranging from no problems to
extreme problems. An interview valuation survey of members of
public in the South Yorkshire was undertaken using the time
trade off (TTO) method. Each respondent was randomly allo-
cated to one of 14 blocks, and valued 7 states each, so that a
total of 98 states were valued. A number of multivariate regres-
sion models were estimated for predicting total 3125 health
states values deﬁned by the reduced classiﬁcation. Models were
compared and selected based on prediction ability and consis-
tency of coefﬁcients. RESULTS: Three hundred and eleven
members of general public were interviewed with 51.4% female
and mean age 42. 42.6% have some OAB symptoms. These
respondents produced a total of 2487 health state values. Mean
health state values range from 0.56 to 1.00, with standard devi-
ations from 0.2 to 0.3. The mean no-constant model was chosen
as the best model. Mean absolute error (MAE) of the best model
was 0.044, with results for the EQ-5D of 0.039. CONCLU-
SIONS: This paper presents a method for deriving QALYs using
existing and future OABq data sets. This will permit the cost
effectiveness of new interventions to be assessed in patients with
OAB.
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OBJECTIVE: Literature on quality of life (QOL) following local
treatment for prostate cancer has primarily focused on compar-
ing treatment modalities rather than speciﬁc age groups. This
analysis explored QOL outcomes in younger men follow-
ing primary curative treatment for localized prostate cancer.
METHODS: Using the CaPSURE (Cancer of the Prostate Strate-
gic Urologic Endeavor) registry, men who underwent radical
prostatectomy (RP) for localized disease and completed the
UCLA Prostate Cancer Index (PCI) pre- and one-year post-
surgery were identiﬁed. Men were grouped by age (<55, 55–64,
°Y´ 65 years). A decline in PCI domains from pre- to post-RP was
deﬁned as a decrease of one standard deviation from the pre-RP
score. Logistic regression was used to analyze predictors of
severe declines. RESULTS: A total of 1143 men were identiﬁed,
with 190, 526, and 427 men in the 3 age groups, respectively.
Younger men had signiﬁcantly higher mean scores one-year after
RP in the urinary function (UF), urinary bother (UB) and sexual
function (SF) domains. A severe decline in SB was more common
in the youngest age group than in the oldest (54% vs. 36%, p <
0.01). With the youngest men as the reference group in the mul-
tivariate model, the oldest age group was 40% less likely to have
a severe decline of SB (OR = 0.60, 95% CI 0.41–0.90, p = 0.04)
but trended toward a higher risk of severe decline in UB (OR =
1.27, 95% CI 0.85–1.89, p = 0.08). CONCLUSIONS: Age pre-
dicts disease-speciﬁc QOL changes at one-year following RP.
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Younger men had signiﬁcantly better mean UF, UB, and SF
domain scores one-year after RP than older men. Men < 55 years
old are more likely than older men to experience a severe decline
of sexual bother but trend toward a lower risk of a severe urinary
bother.
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OBJECTIVES: To compare the performance of a disease speciﬁc
satisfaction measure in overactive bladder (OAB-S) to the generic
Treatment Satisfaction Questionnaire for Medication (TSQM).
METHODS: The OAB-S consists of ﬁve scales (Expectations
with OAB control, Control, Impact on daily living with OAB,
Tolerability, and Satisfaction with OAB control) and ﬁve global
questions related to expectation and satisfaction. The TSQM
consists of four scales (Effectiveness, Convenience, Side effects
and Global satisfaction). The questionnaires were administered
to 134 subjects treated for their OAB with medication at base-
line and two weeks later. RESULTS: All scales on both ques-
tionnaires satisﬁed the minimum recommended level for internal
consistency reliability (Cronbach’s alpha >0.70). The test re-test
reliability of the all scales and individual items on the OAB-S
showed good reliability (ICC > 0.70; weighted Kappa >0.50);
however only the Global satisfaction domain of the TSQM
demonstrated good reliability (ICC = 0.82). The ability of the
questionnaires to discriminate among known groups of patients
based on subject-reported OAB symptoms severity was tested
and the relative validity (RV) was calculated. The RV was higher
for the OAB-S scores compared to the TSQM scores of same
content (e.g., TSQM Side effect RV = 0.08 vs OAB-S Tolerabil-
ity RV = 0.20). The effect sizes for the domains related to the
medication effectiveness were similar for both the TSQM and
OAB-S (TSQM Effectiveness ES = 0.26 vs. OAB Control ES =
0.25); however, the effect sizes for the other domains were higher
for the OAB-S compared to the TSQM indicating better respon-
siveness for the OAB-S. CONCLUSION: The OAB-S is better
able to discriminate patients based on their OAB severity level,
has better responsiveness to change and better reliability com-
pared to the TSQM. The TSQM is a good measure that is appro-
priate to assess satisfaction across different disease states, while
the OAB-S, a disease-speciﬁc measure of satisfaction, is prefer-
able in trials with patients with OAB.
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OBJECTIVE: Previous research has demonstrated that overac-
tive bladder (OAB) impacts 34 million people in the US and
results in $841 million in lost productivity per year. The objec-
tive of this study was to determine whether OAB patients receiv-
ing the transdermal oxybutynin patch experience productivity
improvements. METHODS: Data were obtained from partici-
pants in the Multicenter Assessment of Transdermal Therapy in
Overactive Bladder with Oxybutynin (MATRIX). Patients
enrolled in MATRIX received the oxybutynin patch 3.9mg/day
during this six-month, prospective, multicenter, US study. Self-
reported work productivity was captured at baseline, three and
six-months using the Work Productivity Questionnaire (WPQ),
an 8-question subset of the Work Limitations Questionnaire
(WLQ). The WPQ includes physical, mental (concentration),
time (interruptions and adherence to schedule) and output
(ability to handle workload) scales and a mean WPQ Index was
computed to estimate overall productivity loss. A productivity
loss score was computed to determine the percent reduction of
productivity in study participants compared to healthy individ-
uals. RESULTS: MATRIX enrolled 2878 patients (53.5%
working age [18–64]; 38.9% (n = 1112) employed) at 327 sites.
Of the working age population, 92% were female, 81% were
Caucasian, and the most common occupations noted were pro-
fessional (37%), manager/administrator (14.7%) and sales/retail
(10.4%). WPQ Index data was available for 740 patients at base-
line, 491 at month 3, and 408 at month 6. The mean (SD) WPQ
Index score was 8.2 (6.67) at baseline, and decreased signiﬁ-
cantly at 3-, and 6- months, to 5.8 (5.98), and 5.1 (5.58), respec-
tively (p < 0.0001). Improvements in productivity were observed
at 3- and 6-months across time, mental, physical and output
domains (p < 0.0001). Overall productivity loss decreased from
7.7% at baseline to 5.5% at month 3 and to 4.8% at month 6.
CONCLUSION: Transdermal oxybutynin results in improved
work productivity in patients with OAB.
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OBJECTIVES: This study uses conjoint analysis to examine clin-
ical factors that inﬂuence the decision to use speciﬁc IgE blood
testing as a diagnostic procedure for patients suspected of having
allergic rhinitis. METHODS: Participants included a random
sample of 50 family physicians in Alabama. For the conjoint
analysis physicians evaluated 11 patient proﬁles (repeated 
measures) containing four clinical factors: symptom severity,
symptom length, patient history, and medication use (prescribed
antihistamines, nasal spray, over-the-counter medications). Deci-
sions to test or not test were elicited as dichotomous responses.
Visual analog scales were used to support study validity.
RESULTS: The largest coefﬁcients were obtained for symptom
severity (medium = 2.86; high = 5.12) and symptom length
(medium = 1.04; high = 1.03) with history and medication use
having moderate inﬂuence in the decision process. The overall
conditional logistic model was signiﬁcant (X2 = 194.8, P <
0.001). All physicians sampled valued testing compared to not
testing. For older physicians (age > 50) perceived value compared
to not testing was signiﬁcantly higher (P < 0.05). CONCLU-
SIONS: The value of speciﬁc IgE testing is strongly linked to how
well test results relate to symptoms (severity, length). Family
physicians perceive that speciﬁc IgE blood testing is valuable to
their practice.
